The American Journal of Psychiatry, published by the renowned American Psychiatric Publishing, Inc., stands as a premier platform in the field of Psychiatry and Mental Health. With its inaugural edition released in 1945, this esteemed journal has consistently provided a wealth of knowledge, shaping the landscape of psychiatric research and practice globally. Notably, in the latest 2023 Scopus rankings, it achieved an impressive rank of #7 out of 567 journals in its category, placing it in the top 2% percentile, indicative of its substantial impact within the field. The journal is committed to publishing high-quality, peer-reviewed original research, clinical studies, and reviews that advance psychiatric knowledge and treatment options. Although it does not currently offer open access, its contributions are vital for researchers, clinicians, and students dedicated to improving mental health care and understanding complex mental health disorders. As an essential resource, it continues to foster scholarly communication among professionals who are at the forefront of psychiatric science.

The Iranian Journal of Psychiatry and Clinical Psychology, a distinguished publication by IRAN UNIV MEDICAL SCIENCES, serves as a vital platform for the dissemination of research and advancements in the fields of clinical psychology and psychiatry. With its ISSN 1735-4315 and E-ISSN 2228-7515, the journal reaches a diverse audience of researchers, practitioners, and students, specifically in Iran and the broader international community. This open access journal, based in Tehran, facilitates knowledge sharing through its commitment to exploring contemporary issues and emerging trends from 2018 to 2024. Recognized for its significant contributions, it has achieved a Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories in 2023, alongside Scopus rankings that place it within the lower quartiles of its respective fields. The journal's aim is to foster a deeper understanding of mental health challenges, promote evidence-based practices, and enhance the quality of mental health care, making it an essential resource for advancing academic and clinical excellence.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE is a distinguished publication dedicated to advancing the understanding of psychiatric practice and mental health issues within a medical framework. Published by SAGE PUBLICATIONS INC, this journal has been a trusted source in the field since its inception, with its archives dating back to 1973. It offers a comprehensive exploration of psychiatric research, clinical studies, and theoretical advancements that seek to bridge the gap between psychiatry and general medicine. With an impact factor reflective of its quality and relevance, categorized in the Q3 quartile in Psychiatry and Mental Health, this journal stands as a vital resource for researchers, clinicians, and students alike. Although operating on a traditional subscription model, the extensive knowledge shared within its pages contributes significantly to ongoing discussions in psychiatric and mental health education and practice. As the field continually evolves, the INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE remains committed to fostering innovative and impactful scholarship that resonates with professionals navigating the complexities of mental health in clinical contexts.

Psychoterapia, published by the Polish Psychiatric Association, is an esteemed academic journal dedicated to the fields of clinical psychology and psychiatry. Established in 2001 and continuing its publication until 2023, this journal serves as a significant platform for the dissemination of research, clinical practices, and theoretical advancements in the realm of mental health. Although it currently holds a Q4 ranking in both the Clinical Psychology and Psychiatry and Mental Health categories, it is committed to improving the understanding and treatment of psychological disorders through rigorous peer-reviewed articles. With its ISSN 0239-4170 and E-ISSN 2391-5862, Psychoterapia provides vital insights that are of interest to researchers, clinicians, and students alike. While the journal does not offer open access options, it remains a recommended resource to further stimulate research and dialogue in the field of psychotherapy.

NERVENARZT, published by Springer, has established itself as a significant platform in the fields of Medicine, Neurology, and Psychiatry since its inception in 1947. With a focus on a wide array of topics in neurological and psychiatric health, the journal plays a crucial role in disseminating cutting-edge research and clinical insights that enhance understanding and treatment of neurological disorders. The journal is currently positioned in the Q3 category across various fields, reflecting its role in the academic community, and provides valuable contributions to both the clinical and theoretical aspects of neurology and psychiatry. While it does not offer open access options, NERVENARZT continues to make significant strides in literature with its comprehensive articles and research findings, aimed at researchers, healthcare professionals, and students interested in the latest developments in the neuroscience and mental health landscapes. Operating under rigorous academic standards, it holds respected rankings with Scopus, further underscoring its commitment to impactful scholarship through the years.

Asia-Pacific Psychiatry is a leading academic journal published by WILEY, focused on the diverse and rapidly evolving fields of psychiatry and mental health within the Asia-Pacific region. With an ISSN of 1758-5864 and an E-ISSN of 1758-5872, this journal has been recognized for its significant impact, holding a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in Psychiatry and Mental Health as of 2023. Its commendable Scopus ranking places it at Rank #83 out of 567 in its category, highlighting its influence and relevance in contemporary research. The journal aims to facilitate the dissemination of high-quality research, reviews, and clinical insights that address mental health challenges, promote global understanding, and encourage collaboration among professionals and academics. Although it is not an open-access journal, the high impact factor underscores its value in the scholarly community, making it an essential resource for researchers, clinicians, and students dedicated to enhancing mental health practices and policies in the region and beyond.

Journal of Psychiatric Practice, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of psychiatry and mental health. With a focus on evidence-based clinical practice, the journal has been a respected resource since its inception, providing a platform for a wide range of articles, including original research, reviews, and case reports from 1997 to the present. As of 2023, it holds a Q3 ranking in Psychiatry and Mental Health, reflecting its influential role in the academic community. The Journal is aimed at researchers, mental health professionals, and students, promoting the dissemination of essential knowledge and innovative practices. Subscribers benefit from the latest findings and discussions in the field while contributing to the ongoing advancements in psychiatric care. Although not classified as open access, the journal ensures wide accessibility to its valuable content, further solidifying its commitment to the mental health discipline.

Substance Abuse: Research and Treatment is a premier open-access journal published by SAGE Publications Ltd, focusing on the multifaceted aspects of substance use and its impact on mental health. Since its establishment in 2008, this journal has been dedicated to disseminating innovative research findings, case studies, and reviews that enhance understanding and treatment of substance-related disorders. With an impact factor that reflects its standing in the field, currently ranked in the Q2 category of Psychiatry and Mental Health, Substance Abuse: Research and Treatment strives to foster interdisciplinary dialogue among researchers, practitioners, and students. By making its content freely accessible, the journal encourages widespread engagement and application of evidence-based practices to mitigate substance abuse issues. The journal’s diverse global perspectives make it a vital resource for anyone invested in advancing knowledge and improving treatment outcomes in this critical area of public health.

Journal of Child and Adolescent Psychiatric Nursing is a vital resource for those engaged in the fields of nursing, psychiatry, and pediatrics, dedicated to the advance of knowledge surrounding the mental health needs of children and adolescents. Published by WILEY, this peer-reviewed journal, with ISSN 1073-6077 and E-ISSN 1744-6171, has built a reputation for excellence since its inception in 1988 and continues to contribute significant insights through 2024. The journal holds an impressive Q1 ranking in Pediatrics and a Q2 ranking in Medicine (miscellaneous), underscoring its impact within these critical areas. Enhancing its relevance, it ranks #12/25 in Nursing - Pediatrics and #17/45 in Nursing - Psychiatric Mental Health, highlighting its important niche. Although it currently does not offer open access, the journal remains essential for researchers, clinicians, and students focusing on the complexities of mental health nursing for younger populations, ultimately aiming to improve care strategies and outcomes. Discover compelling research and discussions that shape the future of psychiatric nursing practice, promoting the well-being of children and adolescents.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier academic resource in the field of infectious diseases and microbiology. With its ISSN 0891-5520 and E-ISSN 1557-9824, this esteemed journal has been at the forefront of disseminating critical research findings and clinical advancements since its inception in 1987. Known for its high impact, the journal ranks in the Q1 category for both Infectious Diseases and Medical Microbiology as of 2023, which underscores its significant contribution to advancing knowledge and practice in these vital areas. Researchers, practitioners, and students alike rely on its comprehensive yet concise reviews and original articles, ensuring they stay abreast of emerging trends and therapeutics in infectious disease management. Although it does not offer open access, the journal remains pivotal in enriching scholarly dialogue and influencing clinical practices in the United States and beyond. Explore this vital publication and join a community dedicated to excellence in infectious disease research.